{"id":"tp-62362","type":"article-newspaper","title":"Abivax Shares Fall About 9% After Scorpion Research Short Report","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/62362","datePublished":"2026-11-20T22:40:23.000Z","dateModified":"2026-11-20T22:40:23.000Z","language":"en","abstract":"The report criticized the clinical development of obefazimod, Abivax’s ulcerative colitis candidate. Scorpion Research disclosed a short position in the company.","section":"Business","references":[]}